Cargando…
Ranibizumab and Risk of Hospitalisation for Ischaemic Stroke and Myocardial Infarction in Patients with Age-Related Macular Degeneration: A Self-Controlled Case-Series Analysis
BACKGROUND: Ranibizumab, a vascular endothelial growth factor (VEGF) inhibitor, is used in the treatment of age-related macular degeneration. Inhibition of VEGF has an anti-angiogenic action and is associated with thrombogenicity, thus, myocardial infarction and ischaemic stroke are potential side e...
Autores principales: | Pratt, Nicole L., Ramsay, Emmae N., Kemp, Anna, Kalisch-Ellett, Lisa M., Shakib, Sepehr, Caughey, Gillian E., Ryan, Philip, Graves, Stephen, Roughead, Elizabeth E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242979/ https://www.ncbi.nlm.nih.gov/pubmed/25260802 http://dx.doi.org/10.1007/s40264-014-0231-2 |
Ejemplares similares
-
Comparative effectiveness and safety of low-strength and high-strength direct oral anticoagulants compared with warfarin: a sequential cohort study
por: Pratt, Nicole L, et al.
Publicado: (2019) -
Association between Ophthalmic Timolol and Hospitalisation for Bradycardia
por: Pratt, Nicole L., et al.
Publicado: (2015) -
What is polypharmacy? A systematic review of definitions
por: Masnoon, Nashwa, et al.
Publicado: (2017) -
The validity of the Rx-Risk Comorbidity Index using medicines mapped to the Anatomical Therapeutic Chemical (ATC) Classification System
por: Pratt, Nicole L, et al.
Publicado: (2018) -
Association Between Use of Multiple Psychoactive Medicines and Hospitalization for Falls: Retrospective Analysis of a Large Healthcare Claim Database
por: Pratt, Nicole L., et al.
Publicado: (2014)